Judy E. Garber

Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA)

Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis et al. · Cancer Epidemiology Biomarkers & Prevention · 2012 · 668 citations · Full text

Medicine, Genetics, Oncology +15

Multiple Primary Cancers in Families With Li-Fraumeni Syndrome

Michie Hisada, Judy E. Garber, Frederick P. Li et al. · JNCI Journal of the National Cancer Institute · 1998 · 555 citations · Full text

Medicine, Biostatistics, Oncology +17

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study Group

Timothy R. Rebbeck, Tara M. Friebel, Theresa Wagner et al. · Journal of Clinical Oncology · 2005 · 406 citations

Medicine, Endocrinology, Oncology +17

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

Susan M. Domchek, Tara M. Friebel, Susan L. Neuhausen et al. · The Lancet Oncology · 2006 · 326 citations

Medicine, Oncology, Surgery +7

Modification of BRCA1-Associated Breast Cancer Risk by the Polymorphic Androgen-Receptor CAG Repeat

Timothy R. Rebbeck, Philip W. Kantoff, Krishna Krithivas et al. · The American Journal of Human Genetics · 1999 · 256 citations · Full text

Medicine, Genetics, Molecular Genetics +17